Nanomedicine approaches for

Nanomedicine Immunosuppressive Agents Immunotherapy Neoplasms / therapy
cancer nanomedicine cancer vaccines immuno-oncology immunotherapy lipid nanoparticles mRNA trained immunity

Journal

Nanomedicine (London, England)
ISSN: 1748-6963
Titre abrégé: Nanomedicine (Lond)
Pays: England
ID NLM: 101278111

Informations de publication

Date de publication:
Oct 2023
Historique:
medline: 21 11 2023
pubmed: 19 9 2023
entrez: 19 9 2023
Statut: ppublish

Résumé

Tweetable abstract Commentary just out in @fsgnnm: unleashing the full potential of #cancer #nanomedicines by reprogramming the immunosuppressive #TME using #LNP #mRNA #vaccines and via promoting #trainedimmunity.

Identifiants

DOI: 10.2217/nnm-2023-0230 PMID: 37724504
pubmed: 37724504
doi: 10.2217/nnm-2023-0230
doi:

Substances chimiques

Immunosuppressive Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1607-1611

Subventions

Organisme : Nederlandse Organisatie voor Wetenschappelijk Onderzoek
ID : 19681

Auteurs

Stijn Rj Hofstraat (SR)

Laboratory of Chemical Biology, Department of Biomedical Engineering & Institute for Complex Molecular Systems, Eindhoven University of Technology, Eindhoven, 5612 AE, The Netherlands.
ORCID: 0000-0003-2120-5171

Tom Anbergen (T)

Department of Internal Medicine & Radboud Center for Infectious Diseases (RCI), Radboud University Medical Center, Nijmegen, 6525 GA, The Netherlands.
ORCID: 0000-0002-7155-7709

Roy van der Meel (RV)

Laboratory of Chemical Biology, Department of Biomedical Engineering & Institute for Complex Molecular Systems, Eindhoven University of Technology, Eindhoven, 5612 AE, The Netherlands.
ORCID: 0000-0002-2200-7946

Articles similaires

Spatial multiplex analysis of lung cancer reveals that regulatory T cells attenuate KRAS-G12C inhibitor-induced immune responses.

Megan Cole, Panayiotis Anastasiou, Claudia Lee et al.
1.00
T-Lymphocytes, Regulatory Lung Neoplasms Proto-Oncogene Proteins p21(ras) Animals Humans

Patients' knowledge about renal secondary effects of anti-tumoral drugs and renal protection measures.

Pauline Corbaux, Matthieu Bainaud, Adrien Rousseau et al.
1.00
Humans Male Female Health Knowledge, Attitudes, Practice Middle Aged

Perceived risk of death among patients with advanced cancer: a qualitative directed content analysis.

Guojuan Chen, Zhangxian Chen, Huimin Xiao et al.
1.00
Humans Neoplasms Male Female Middle Aged

Cultural adaptation and validation of the Sinhala version of the spiritual needs assessment for patients (S-SNAP) questionnaire.

Udayangani Ramadasa, Shehan Silva, Suraj Perera et al.
1.00
Humans Middle Aged Female Male Surveys and Questionnaires

Classifications MeSH

questionsmedicales.fr › Technologie, industrie et agriculture › Technologie › Miniaturisation › Nanotechnologie › Nanomédecine › Nanomedicine approaches for
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Effets physiologiques des médicaments › Facteurs immunologiques › Immunosuppresseurs › Nanomedicine approaches for
questionsmedicales.fr › Thérapeutique › Biothérapie › Immunothérapie › Nanomedicine approaches for
questionsmedicales.fr › Tumeurs › Nanomedicine approaches for